doxepin has been researched along with Colitis, Mucous in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A self-control and follow-up study on subclinical dosage of antidepressants therapy (fluoxetine 10 mg/d, paroxetine 10 mg/d or doxepin 45 mg/d) for 9-12 wks in 46 patients with refractory IBS symptoms according to Rome II criteria was performed, the clinical outcomes were evaluated by scales changes of symptom-related-anxiety, severity index of symptom, and quality of life specific of IBS, as well as general psychiatric health by SCL-90 during treatment and follow-up periods." | 1.32 | [Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants]. ( Pan, GZ; Qian, JM; Wang, WA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukudo, S | 1 |
| Kano, M | 1 |
| Sato, Y | 1 |
| Muratsubaki, T | 1 |
| Kanazawa, M | 1 |
| Tashiro, M | 1 |
| Yanai, K | 1 |
| Wang, WA | 1 |
| Qian, JM | 1 |
| Pan, GZ | 1 |
1 review available for doxepin and Colitis, Mucous
| Article | Year |
|---|---|
Histamine Neuroimaging in Stress-Related Disorders.
Topics: Animals; Brain; Depressive Disorder, Major; Doxepin; Female; Histamine; Humans; Hypnotics and Sedati | 2022 |
1 other study available for doxepin and Colitis, Mucous
| Article | Year |
|---|---|
[Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants].
Topics: Adult; Antidepressive Agents; Doxepin; Female; Fluoxetine; Follow-Up Studies; Humans; Irritable Bowe | 2003 |